ClinVar Miner

Submissions for variant NM_004614.5(TK2):c.402G>T (p.Arg134Ser)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Neuberg Centre For Genomic Medicine, NCGM RCV003337955 SCV004048417 likely pathogenic Mitochondrial DNA depletion syndrome, myopathic form criteria provided, single submitter clinical testing The missense variant p.R134S in TK2 (NM_004614.5) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.R134S variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. There is a moderate physicochemical difference between arginine and serine. The p.R134S missense variant is predicted to be damaging by both SIFT and PolyPhen2. The arginine residue at codon 134 of TK2 is conserved in all mammalian species. The nucleotide c.402 in TK2 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. Since the variant is present in trans with a Likely pathogenic variant, Therefore for these reasons the variant has been classified as Likely Pathogenic. The observed variant was also detected in heterozygous state in the father.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.